T1	Participants 66 86	patients with cancer
T2	Participants 1155 1221	342 participants from the ongoing ESRA-C randomized clinical trial
T3	Participants 1223 1427	Research participants for the ESRA-C study were recruited from the Seattle Cancer Care Alliance, a consortium among the University of Washington Medical Center, Fred Hutchinson Cancer Research Center, and
T4	Participants 1439 1490	Hospital and Regional Medical Center in Seattle, WA
T5	Participants 1516 1538	342 adult participants
